ArticleClinical hypertension2025
Feasibility of watch-based blood pressure monitoring device in daily blood pressure monitoring.
Article in Clinical hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Validation of ring-type cuffless blood pressure (BP) monitoring device for detecting awake-asleep BP variations compared to ambulatory BP monitoring device.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Clinical impact of proteinuria and blood pressure variability on long-term outcomes after percutaneous coronary intervention.Scientific reports · 2026Observational
- Identifying barriers to the acceptability and adoption of ambulatory blood pressure monitoring and proposed strategies in Bangladesh, Pakistan, and Sri Lanka: a qualitative study.BMC health services research · 2026Article
- Wearable, cuffless, and portable devices for blood pressure monitoring (2015-2025): a scoping review of technologies, calibration, clinical validation, and regulatory frameworks.Frontiers in digital health · 2026Article
- Real-world performance of a ring-type cuffless blood pressure device compared with ambulatory blood pressure monitoring.Clinical hypertension · 2026Article
- To be (IIb), or not to be (IIb) - That is the current status of cuffless blood pressure monitoring device.Clinical hypertension · 2026Review
- Design and prototyping of an AI-powered wearable device for continuous vital signs monitoring with intelligent alerting.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cuffless blood pressure (BP) measurement devices integrated into smartwatches have gained prominence, yet limited studies provide the feasibility and preciseness of daily BP monitoring. Here, we evaluated the trackability of daily BP variance and the precision of the calibration process. Methods: We collected the data from 896 participants, reporting 35,592 BP values, and body composition analysis data measured by the Samsung Galaxy Watch 6 device. Participants were instructed to measure BP daily, in the morning (5 AM-9 AM) and evening (6 PM-10 PM) for 2 weeks, with initial calibration and re-calibration after the first week. Body composition data, obtained using the Galaxy Watch's bioelectrical impedance analysis sensor, was measured voluntarily during the campaign without specific time constraints. Results: With BP readings collected using smartwatches, morning and evening BP values showed a significant difference, higher in the evening by 1.42 ± 5.25 mmHg ( Conclusions: In conclusion, watch-based devices may not detect clinical-level BP variability, and substantial extent of pre-post calibration error has to be solved for their utility in regular real-life BP monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.